C4 Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

C4 Therapeutics, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 2 are pending. Notable registered marks include BIDAC, MONODAC, TORPEDO, DAEDALUS, and C4 THERAPEUTICS. The owner is based in Watertown, MA.

490 Arsenal Way, Suite 200

Watertown, MA 02472

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

C4 Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (10 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does C4 Therapeutics, Inc. have?

C4 Therapeutics, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 8 registered, 2 pending, 5 abandoned.

What trademark classes does C4 Therapeutics, Inc. file in?

C4 Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are C4 Therapeutics, Inc.'s most well-known trademarks?

C4 Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as BIDAC, MONODAC, TORPEDO, DAEDALUS, and C4 THERAPEUTICS. These are among 8 currently registered trademarks in the portfolio.

What is C4 Therapeutics, Inc.'s trademark registration success rate?

C4 Therapeutics, Inc. has a 62% trademark registration rate, with 8 out of 13 resolved applications resulting in successful registration. Currently, 2 applications are pending review.